151 doctors in the Medifly network
Dr. Aiden Heng Fook YewCancer · Kuching
Dr Aiden Heng Fook Yew is a Clinical Oncologist specialising in cancer diagnosis, treatment planning, and systemic therapy.
Conditions treated
Chemotherapy & Immunotherapy · Solid Tumour Management
Dr. Karmen Wong
黄洁儿医生Cancer · Singapore
Medical oncologist specializing in breast, gastrointestinal, and gynecological cancers with extensive experience in multidisciplinary cancer care
Conditions treated
Breast Cancer · Gastrointestinal Oncology
Dr Daniel Wong Wai YanMRCP (UK)Cancer · Melaka City
Dr Daniel Wong Wai Yan is a Clinical Oncologist specialising in cancer diagnosis, radiotherapy, and systemic cancer treatments.
Conditions treated
Radiation Oncology · Solid Tumour Management
Dr Ng Boon HuatCancer · Petaling Jaya
Consultant Clinical Oncologist at Beacon Hospital specialising in adult malignancies and advanced radiotherapy, with expertise in systemic cancer therapies.
Conditions treated
Advanced Radiotherapy Techniques · Systemic Cancer Therapy
Dr. Santhi A/P NadarajanCancer · Kuala Lumpur
Clinical oncologist specialising in cancer diagnosis, radiotherapy, and multidisciplinary cancer care.
Conditions treated
Solid Tumour Treatment · Precision Radiotherapy
Dr. Shang Yeap Heng Oon 叶昇运医生Cancer · Singapore
Dr. Shang Yeap Heng Oon is a Medical Oncologist specialising in breast, gastrointestinal, lung, urogenital cancers, and melanoma treatment.
Conditions treated
Breast Cancer · Clinical Trials
Assoc. Prof. Dr. Aminudin Rahman Mohd MydinFRCR (UK)20+ years of experience · Cancer · Petaling Jaya
Consultant Clinical and Radiation Oncologist with expertise in advanced radiotherapy, chemotherapy, immunotherapy, and cancer care.
Conditions treated
Radiation Oncology · Advanced Radiotherapy Techniques
Zee Ying KiatCancer · Singapore
Dr Zee Ying Kiat is a medical oncologist at Mount Elizabeth Hospital, Singapore. He is well-versed in general medical oncology and has special interests in gastro-oesophageal, hepatobiliary, pancreatic, and colorectal cancers. He was a consultant medical oncologist at the National University Cancer Institute, Singapore (NCIS). Dr Zee graduated from the University College London, UK. He worked at the Royal Marsden Hospital in London before completing specialist training in medical oncology at the National University Hospital. He subsequently underwent fellowship training at The Christie Hospital and Paterson Institute for Cancer Research in Manchester, UK, where his focus was on anti-cancer drug development. He is a member of the American Society of Clinical Oncology and founding member of the Hepatopancreatobiliary Association of Singapore. He is the board member of the Mount Elizabeth Hospital’s medical advisory board, the National Healthcare Group's domain specific review board and the chapter of medical oncologists, College of Physicians, Singapore. His commitment to research has been recognised through various grants including the National Medical Research Council’s clinician investigator support grant and NCIS investigator protected time grant. At NCIS, he conducted clinical and translational research as principal or co-investigator in local and international trials involving novel targeted therapies for colorectal, gastric, liver and pancreatic cancers. He has published his work as first author in various journals including the British Journal of Cancer, Journal of Clinical Oncology, Lancet Oncology and Nature Reviews. Dr Zee is a recipient of the Excellent Service Award from SPRING Singapore.
Conditions treated
Gastrointestinal Cancers · Hepatopancreatobiliary Malignancies
Tanujaa D/O RajasekaranMRCP (UK)Cancer · Singapore
Dr Tanujaa Rajasekaran is a medical oncologist at Mount Elizabeth Hospital, Singapore. She is experienced in general medical oncology, with subspecialty interests in the management of lung, genitourinary, head and neck cancers, and geriatric oncology. Prior to joining private practice, Dr Tanujaa was a consultant at the National Cancer Centre Singapore (NCCS) and medical director at Changi General Hospital’s oncology unit. She graduated from the National University of Singapore (NUS). Thereafter, she obtained her master’s from NUS and membership of the Royal College of Physicians, UK. Subsequently, she went on to complete her specialist training in medical oncology at NCCS. She has been practising medicine for more than 15 years. Beyond her clinical work, Dr Tanujaa is actively involved in medical education. She was a core faculty member of the medical oncology senior residency programme and a clinical lecturer at Yong Loo Lin School of Medicine, NUS. She was also an assistant professor at Duke-NUS Medical School. She has published in several internationally renowned journals. She is a member of the American Society of Clinical Oncology, European Society of Medical Oncology and International Society of Geriatric Oncology (SIOG). She is also Singapore’s national representative for SIOG. Dr Tanujaa has received numerous awards including the SingHealth Quality Service awards.
Conditions treated
Lung Cancer · Genitourinary Cancers
Chin Tan MinCancer · Singapore
Dr Chin Tan Min is a medical oncologist at Gleneagles Hospital and Mount Elizabeth Hospitals, Singapore. Her areas of expertise lie in lung cancers and general oncology. She was awarded the Health Manpower Development Programme (HMDP) fellowship to pursue further subspecialisation training in thoracic oncology, with a clinical and research fellowship at the Massachusetts General Hospital Cancer Centre in the US. Prior to private practice, she was a senior consultant at the National University Cancer Institute at NUH, and a visiting consultant at Ng Teng Fong Hospital. Dr Chin contributes her expertise in thoracic oncology in various Ministry of Health committees, formulating guidelines on screening and treatment for lung cancers. She is also an advisory member for lung cancer for Singapore Cancer Society, and has been involved in educational talks for the public. She was also core faculty for the oncology senior residency programme at National University Health System. She is the principal associate at the Cancer Science Institute of Singapore, where she continues her current research. She is a member of American Society of Clinical Oncology, American Association for Cancer Research, and the International Association of Lung Cancer. With a keen and active interest in translational and clinical research to better patient care, she has conducted several international industry-sponsored and investigator-initiated clinical trials as principal and co-investigator. Dr Chin’s work has been published in peer-reviewed, high-impact factor journals such as Nature, Nature Medicine and Journal of Clinical Oncology. She contributed to the development of EGFR mutation detection test/kit in lung cancers, in both tumour and blood. Her commitment to patient care has been recognised by SPRING’s Excellent Service Award.
Conditions treated
Lung Cancer · Thoracic Oncology
Showing 12 of 151
